Ro Khanna's Congressional Trading: A Deep Dive into His $450K Investments

Friday, 18 October 2024, 15:24

Congressional trading is in the spotlight as Ro Khanna has disclosed $450K in stock investments. This includes notable purchases in tech stocks Aon and CrowdStrike, raising ethical questions.
Finbold
Ro Khanna's Congressional Trading: A Deep Dive into His $450K Investments

Congressional trading is making headlines with Representative Ro Khanna of California's 17th district recently disclosing a staggering $450K in stock investments.

His transactions, encompassing over 200 trades, predominantly feature investments in tech stocks like Aon (NYSE: AON) and CrowdStrike (NASDAQ: CRWD).

Investments Under Scrutiny

Khanna, affiliated with the Democratic Party's progressive wing, has openly advocated for banning politician stock trading. However, his committee assignments have recently raised eyebrows regarding ethical implications.

  • Notable Investments: Aon and CrowdStrike.
  • Total Transactions: Over 200, valued at $450K.
  • Ethical Quandary: Access to non-public information.

Potential Profits from Stock Picks

Khanna's purchase patterns reveal significant volatility and potential for profit in his chosen stocks. Aon saw a price increase of approximately 3.4% since his purchases, while CrowdStrike's stock surged, yielding returns as high as 24.84%.

  1. Aon Trends: Trading between $345 and $348.
  2. CrowdStrike Trends: Trading jumps from $246.58 to $307.84.

Overall, while his investments are diversified, the current filing system may obscure the full extent of his financial gains, presenting a stark reminder of potential conflicts in congressional trading.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe